Now that the Medicare re-enrollment period has arrived (Oct. 15-Dec. 7), senior Americans are exposed to ubiquitous advertisements, phone calls, and other mechanisms to convince them to enroll in Medicare Advantage rather than traditional Medicare plans.Â
Howard Meyers, of Dallas, Texas, a member of The University of Texas MD Anderson Cancer Center Board of Visitors, has donated $25 million to MD Anderson Cancer Center to establish the Meyers Institute for Oncology Nursing.
MD Anderson Cancer Center launched its Institute for Data Science in Oncology, or IDSO, which integrates the most advanced computational and data science approaches with the institution’s extensive scientific and clinical expertise to significantly improve patient’s lives by transforming cancer care and research.
Agnes Hsu, a clinical nurse, has received the 2023 Brown Foundation Award for Excellence in Oncology Nursing from MD Anderson Cancer Center.
Alejandro Aballay, an expert in immune signaling and graduate education, was named dean of the MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, effective Jan. 2, 2024.
MD Anderson Cancer Center has established the Texas Health Equity Alliance for Breast Cancer (THEAL), a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women.
MD Anderson Cancer Center has broken ground on a 600,000-square-foot facility intended to anchor the institution’s south campus research park.Â
Researchers at MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer. The combination therapy led to durable tumor elimination and significantly improved survival outcomes in preclinical models, leading to the launch of a phase I clinical trial.
Irwin H. Krakoff, former director of the University of Vermont Cancer Center who has also served in key jobs at Memorial Sloan-Kettering Cancer Center and MD Anderson Cancer Center, died on Aug. 9 in Savannah, GA.
Christopher Flowers was named head of the Division of Cancer Medicine at MD Anderson Cancer Center after a competitive national search.Â
